Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
about
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococciMaternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspringDiscovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesInterleukin-17A mediates acquired immunity to pneumococcal colonizationDiversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.Pooled protein immunization for identification of cell surface antigens in Streptococcus sanguinisImmunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationInteraction of pneumococcal histidine triad proteins with human complement.The two-component signal transduction system RR06/HK06 regulates expression of cbpA in Streptococcus pneumoniae.Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse modelEndogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres.Lipoproteins of bacterial pathogens.Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease.Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection modelNatural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.Pneumococcal vaccination and revaccination of older adults.Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein DImpairment of pneumococcal antigen specific isotype-switched Igg memory B-cell immunity in HIV infected Malawian adults.Effect of heat shock and mutations in ClpL and ClpP on virulence gene expression in Streptococcus pneumoniae.Expression of the type 1 pneumococcal pilus is bistable and negatively regulated by the structural component RrgATwo DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood.Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.Characterization of Pneumococcal Genes Involved in Bloodstream Invasion in a Mouse ModelSerotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunityRecent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage.ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies.Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.
P2860
Q24548662-5F3F9D42-1363-4DBA-8668-BC6C9E97176AQ28743311-60E3953E-C9BD-4C13-B983-3C090946D916Q33312893-85FDC095-46AF-47D5-A260-24DD077A2418Q33370537-4F5A442F-4F13-4C89-B7C3-F869AEE43186Q33592652-3566E792-0E9E-435B-96E4-B5B8E46CA1F9Q33644475-A627C012-26B3-49CE-B537-D21FFC867000Q33725192-BB4B53B1-43A7-46D9-897D-C46E336BC699Q33820413-30A02443-EF3B-4E16-88D5-7B14D39D35B1Q33826119-B00DAA9E-13BC-4423-A476-AC361BF1B3E5Q33836238-9AF95BEB-E753-4AE4-907D-67E6057AF7DCQ33963100-3E1E5601-A39D-408C-8A3F-FC24628C4ED7Q34009174-9C58B963-EFFF-40A7-B804-0F8A67390B25Q34020348-ECBD46C7-E72E-45AC-A29F-9A77E1559311Q34033151-26770C25-72A5-4C10-A400-5973684E3DBFQ34033275-302628FB-73A9-4C78-BAC7-D7B87D61B833Q34118627-DAC21143-B535-4BE6-8D8E-207859042F5FQ34120517-BCDC1BF4-7C32-46F0-BFFA-C6EB5C332A88Q34145626-AE96F13E-74E0-47F0-8237-0250BAE669B5Q34229627-B2BE792F-0CD7-4B9A-9072-8E381CE4C1B8Q34310321-3796A949-0220-425C-B4B1-AF5007CC6D26Q34484575-5377119E-EC2B-427A-870A-A3C0D9F94FDCQ34637890-49019D35-74B2-4905-A225-9DEE2D3BAFE2Q34694425-9C10FE85-6576-4F8F-881E-692D17F411E3Q34713678-96FE611D-2679-4AB5-8F52-80994FE4F1F7Q34740228-5EA0E2A5-7620-490C-847F-DF7E203AAF61Q34779050-BA7E0370-C165-4E7F-8237-B29E618BCAA2Q34926870-2FBD8BFF-9C4A-404B-A11E-E73CC72E837DQ35036855-1107CDCE-4A49-4CA0-8677-D135167BB69FQ35040976-1D0596A7-C14C-4F0A-B8C6-F16817ED721EQ35106443-05EA4200-D250-44E3-842E-D95D560FD50EQ35139321-3012EEE0-D0A4-46E1-95C0-8A7428D767C8Q35191928-44437F05-8075-4158-BA96-FA0170051318Q35272956-636ABCF4-2FCC-423E-A270-43D066B1EC53Q35689099-2568B672-3955-495C-B006-097F806B1B83Q35783885-0D7E32B6-C1D9-4384-9FA4-9749C6E5D40DQ35833224-ED53DE2C-DD49-43CA-B19D-4D1F3BEE4387Q35844906-B67FAEC0-8ACB-4AA5-A815-1E11BB0C4B6AQ35946160-58EFF725-8763-45F9-83CE-A25A165B570CQ35959243-2BF3997A-589C-4849-BF93-8A38E638F708Q36005317-98362C34-9F9A-44BA-9A66-B4F2D1A5697A
P2860
Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@ast
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@en
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@nl
type
label
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@ast
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@en
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@nl
prefLabel
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@ast
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@en
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@nl
P2093
P2860
P1476
Immunization of mice with comb ...... with Streptococcus pneumoniae.
@en
P2093
A D Ogunniyi
D E Briles
R L Folland
S K Hollingshead
P2860
P304
P356
10.1128/IAI.68.5.3028-3033.2000
P407
P577
2000-05-01T00:00:00Z